Grünenthal & Averitas Recruits for QUTENZA® Ph 3in Neuropathic Pain
07 Nov 2024 //
PR NEWSWIRE
Veritas Collaborative Partners With Project HEAL to Make Large-Scale Commitment
14 Sep 2022 //
GLOBENEWSWIRE
Grünenthal and Averitas Pharma announce initiation of Phase III study
30 Mar 2021 //
PRNEWSWIRE
Growth for Grünenthal with new Qutenza indication
22 Jul 2020 //
THEPHARMALETTER
Grünenthal and Averitas Pharma Announce U.S. FDA Approval of QUTENZA®
21 Jul 2020 //
GRUNENTHAL
Averitas Pharma Announces FDA Acceptance of sNDA Filing for QUTENZA® (capsaicin)
18 Dec 2019 //
PR NEWSWIRE